Floatz logo

Atezolizumab

Vulvar Cancer

University of Floridamonoclonal_antibodyPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Vulvar Cancer cohort.

Asset / SponsorPhaseRating
Indocyanine Green
Istanbul University
Phase 4BB
TECHNETIUM-99
Institut de Cancérologie de Lorraine
Phase 3B
Octreotide Pamoate
Alliance for Clinical Trials in Oncology
Phase 3B
e7 tcr-t cells
Christian Hinrichs
Phase 2B
Durvalumab
M.D. Anderson Cancer Center
Phase 2B

View all 34 →

Same molecule, other indications

Atezolizumab is also rated in:

metastatic neoplasmDormant
BB
Indicative ·
71 / 100
View asset →
Stage IV Lung Cancer AJCC v8Dormant
BB
Indicative ·
70 / 100
View asset →
Her2-receptor negative breast cancerDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →